Neuroinflammation Hypothesis in Alzheimer's Disease
📖 Wiki Page
mechanism1345 wordssynced 2026-04-02
Neuroinflammation Hypothesis in Neurodegeneration
Introduction
The neuroinflammation hypothesis proposes that chronic, dysregulated neuroinflammation is a primary driver of neurodegenerative disease pathogenesis, not merely a secondary response to protein aggregation or neuronal injury. This hypothesis has gained significant traction over the past two decades with the recognition that microglial activation, astrocyte reactivity, and peripheral immune infiltration contribute substantially to disease progression in Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and other neurodegenerative conditions [1](https://pubmed.ncbi.nlm.nih.gov/32877962/). [@liddelow2017]
Historical Context
The neuroinflammation hypothesis evolved from the Janus-faced concept of inflammation—inflammation serves protective functions acutely but becomes detrimental when chronic. Key historical milestones: [@piwecka2023]
1990s: Initial observations of activated microglia in AD and PD brains
2000s: Recognition of [complement system](/entities/complement-system) involvement in synaptic pruning
2017: TREM2 variants identified as major AD risk factors
2020s: Single-cell transcriptomics revealed disease-associated microglia (DAM) and astrocyte (A1/A2) states
Mechanistic Framework
Neuroinflammation as Primary vs. Secondary Event
The debate continues whether neuroinflammation is: [@jonsson2013]
...
Neuroinflammation Hypothesis in Neurodegeneration
Introduction
The neuroinflammation hypothesis proposes that chronic, dysregulated neuroinflammation is a primary driver of neurodegenerative disease pathogenesis, not merely a secondary response to protein aggregation or neuronal injury. This hypothesis has gained significant traction over the past two decades with the recognition that microglial activation, astrocyte reactivity, and peripheral immune infiltration contribute substantially to disease progression in Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and other neurodegenerative conditions [1](https://pubmed.ncbi.nlm.nih.gov/32877962/). [@liddelow2017]
Historical Context
The neuroinflammation hypothesis evolved from the Janus-faced concept of inflammation—inflammation serves protective functions acutely but becomes detrimental when chronic. Key historical milestones: [@piwecka2023]
1990s: Initial observations of activated microglia in AD and PD brains
2000s: Recognition of [complement system](/entities/complement-system) involvement in synaptic pruning
2017: TREM2 variants identified as major AD risk factors
2020s: Single-cell transcriptomics revealed disease-associated microglia (DAM) and astrocyte (A1/A2) states
Mechanistic Framework
Neuroinflammation as Primary vs. Secondary Event
The debate continues whether neuroinflammation is: [@jonsson2013]
Primary driver: Genetic risk variants in microglial genes (TREM2, PLCG2, ABI3) directly cause dysfunction
Amplification loop: Initial amyloid/tau pathology triggers inflammation, which accelerates protein aggregation
Failed repair response: Inflammation attempts to clear pathology but becomes chronic and harmful
Current evidence suggests all three mechanisms operate in different disease stages and contexts. [@chen2023]
Central Players in Neuroinflammation
Microglia
[Microglia](/cell-types/microglia-neuroinflammation) are the resident immune cells of the central nervous system (CNS), derived from embryonic yolk sac progenitors. In neurodegeneration, they: [@heneka2015]
Survey the brain: Continuously scan for pathogens and damage signals
Phagocytose debris: Clear dead cells, protein aggregates, and synaptic material
A2 astrocytes: Produce neurotrophic factors and promote tissue repair [2](https://pubmed.ncbi.nlm.nih.gov/28648359/)
Peripheral Immune Cells
T cells: CD4+ and CD8+ T cells infiltrate the brain in AD and PD
B cells: Autoantibodies and B cell infiltration observed in some cases
Monocytes/macrophages: May enter the CNS and adopt inflammatory phenotypes
Disease-Specific Mechanisms
Alzheimer's Disease
Amyloid-Tau-Inflammation Loop
The synergistic interaction between amyloid-β (Aβ) and tau pathology drives neuroinflammation in AD [3](https://pubmed.ncbi.nlm.nih.gov/37643161/): [@gate2020]
Aβ deposition activates microglia via pattern recognition receptors (PRRs)
[Tau](/proteins/tau) pathology spreads along neural networks, activating microglia in connected regions
Aβ∙tau complex specifically activates microglia through TREM2-dependent mechanisms
Chronic activation leads to DAM phenotype, synaptic loss, and neuronal death
[Alzheimer's Disease Neuroimaging Initiative (ADNI)](https://adni.loni.usc.edu/) - Research data on neuroinflammation biomarkers
[Human Cell Atlas - Brain](https://www.humancellatlas.org/) - Single-cell microglial data
[AMP-AD Consortium](https://www.nia.nih.gov/research/amp-ad) - Alzheimer's disease program
Background
The study of Neuroinflammation Hypothesis In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.